165669-35-2

Basic information

• Product Name: 7-BROMO-1H-PYRROLO[2,3-C]PYRIDINE
• Synonyms: 7-Bromo-1H-pyrrolo[2,3-c]pyridine;1H-Pyrrolo[2,3-c]pyridine, 7-bromo-;7-BroMo-6-azaindole
• CAS NO: 165669-35-2
• Molecular Formula: C₇H₅BrN₂
• Molecular Weight: 197.03
• Mol File: 165669-35-2.mol
• Article Data: 6

Chemical Properties

• Melting Point: 174-178°C
• Boiling Point: 362°Cat760mmHg
• Flash Point: 172.7°C
• Appearance: /
• Density: 1.77g/cm³
• Vapor Pressure: 4.17E-05mmHg at 25°C
• Refractive Index: 1.727
• Storage Temp.: 2-8°C
• PKA: 12.99±0.40(Predicted)
• CAS DataBase Reference: 7-BROMO-1H-PYRROLO[2,3-C]PYRIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 7-BROMO-1H-PYRROLO[2,3-C]PYRIDINE(165669-35-2)
• EPA Substance Registry System: 7-BROMO-1H-PYRROLO[2,3-C]PYRIDINE(165669-35-2)

Safety Data

• Hazard Codes: T
• Statements: 25-37/38-41
• Safety Statements: 26-36/37/39-45
• RIDADR: UN 2811 6.1 / PGIII
• WGK Germany: 3
• Hazardous Substances Data: 165669-35-2(Hazardous Substances Data)

Usage

General Description

7-Bromo-1H-pyrrolo[2,3-c]pyridine is a chemical compound with the molecular formula C7H4BrN3. It is a heterocyclic compound containing a pyrrole ring fused to a pyridine ring, and a bromine atom attached to the carbon position 7. This chemical is commonly used in the pharmaceutical industry as a building block for the synthesis of various biologically active compounds. Its unique structure and reactivity make it a valuable intermediate in the development of potential drugs and agrochemicals. Additionally, 7-Bromo-1H-pyrrolo[2,3-c]pyridine has also been studied for its potential applications in the field of materials science, particularly in the development of organic electronic and optoelectronic devices due to its conjugated system and electron-rich nature.

InChI:InChI=1/C7H5BrN2/c8-7-6-5(1-3-9-6)2-4-10-7/h1-4,9H

Upstream product

• 165669-36-3 1H-pyrrolo[2,3-c]pyridine-7-amine 
• 19755-53-4 2-bromo-3-nitropyridine 
• 1826-67-1 vinyl magnesium bromide 

Downstream Products

• 165669-36-3 1H-pyrrolo[2,3-c]pyridine-7-amine 
• 1265023-89-9 7-bromo-1-(4-methoxysulfonyl)-6-azaindole 
• 1265022-42-1 7-phenyl-1-(4-methoxybenzenesulfonyl)-6-azaindole 
• 1265022-24-9 7-anilino-1-(4-methoxybenzenesulfonyl)-6-azaindole 
• 1265022-38-5 7-(4-fluoroanilino)-1-(4-methoxybenzenesulfonyl)-6-azaindole 
• 1265022-58-9 7-(4-hydroxyphenyl)-1-(4-methoxybenzenesulfonyl)-6-azaindole 
• 1265022-62-5 1-(4-methoxybenzenesulfonyl)-7-(4-methoxyphenyl)-6-azaindole 
• 1265022-50-1 7-(4-fluorophenyl)-1-(4-methoxybenzenesulfonyl)-6-azaindole 
• 1265022-66-9 7-(4-(N,N-dimethylaminophenyl))-1-(4-methoxybenzenesulfonyl)-6-azaindole 
• 1265022-54-5 7-(4-chlorophenyl)-1-(4-methoxybenzenesulfonyl)-6-azaindole 
• 1265022-78-3 1-(4-methoxybenzenesulfonyl)-7-(4-trifluoromethylphenyl)-6-azaindole 
• 1265022-74-9 1-(4-methoxybenzenesulfonyl)-7-(4-nitrophenyl)-6-azaindole 
• 1265022-70-5 1-(4-methoxybenzenesulfonyl)-7-(pyridin-4-yl)-6-azaindole 
• 1265022-82-9 7-(2-furanyl)-1-(4-methoxybenzenesulfonyl)-6-azaindole 

Relevant articles and documents

HETEROCYCLIC COMPOUNDS AS PROTEIN KINASE INHIBITORS

The present invention provides a heterocyclic compound of formula (I), a pharmaceutically acceptable salt thereof, a prodrug thereof or a hydrate thereof, wherein A, A′ B, D, R1, R2 and R3 are as defined herein, a pharmaceutical composition comprising a compound of formula (I) as an active ingredient, methods of production, and methods of use thereof. Particularly, the present invention provides a compound of formula (I) useful for treating or preventing a disease, condition or disorder associated with protein kinases, preferably Janus Kinase family.

HETEROCYCLIC COMPOUNDS AS PROTEIN KINASE INHIBITORS

The present invention provides a heterocyclic compound of formula (I), a pharmaceutically acceptable salt thereof, a prodrug thereof or a hydrate thereof, wherein A, A' B, D, R1, R2 and R3 are as defined herein, a pharmaceutical composition comprising a compound of formula (I) as an active ingredient, methods of production, and methods of use thereof. Particularly, the present invention provides a compound of formula (I) useful for treating or preventing a disease, condition or disorder associated with protein kinases, preferably Janus Kinase family.

Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives

This invention provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the invention is concerned with azaindoleoxoacetyl piperazine derivatives. These compounds possess unique antiviral activity, whether used alone or in combination with other antivirals, antiinfectives, immunomodulators or HIV entry inhibitors. More particularly, the present invention relates to the treatment of HIV and AIDS.